July 7, 2020 / 10:14 PM / a month ago

BRIEF-FDA Approves New Therapy For Myelodysplastic Syndromes That Can Be Taken At Home

July 7 (Reuters) - FDA:

* FDA APPROVES NEW THERAPY FOR MYELODYSPLASTIC SYNDROMES THAT CAN BE TAKEN AT HOME

* FDA - APPROVED INQOVI TABLETS FOR TREATMENT OF ADULT PATIENTS WITH MYELODYSPLASTIC SYNDROMES & CHRONIC MYELOMONOCYTIC LEUKEMIA

* FDA - GRANTED APPROVAL OF INQOVI TO ASTEX PHARMACEUTICALS, INC., A SUBSIDIARY OF OTSUKA PHARMACEUTICAL CO. LTD Source text: (bit.ly/2VZadRg) Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below